what is the sepsis innovation collaborative
PERSOWN is proud to partner with esteemed clinical, academic, research, and patient advocacy partners on the common mission of managing infections, addressing the global sepsis concern and improving patient care while strengthening the worlds healthcare system. For more information, please read this overview of the Sepsis Innovation Collaborative.
PERSOWN is dedicated to working with our partners to address the challenges and needs of clinicians and patients for sepsis detection, treatment, management and survivor support; working toward the following goals.
- Furthering communication across both public and private sectors to accelerate innovation
- Improving access to sepsis detection, treatment, and management
- Establishing a common sepsis case definition
- Accelerating time-to-market of innovative technologies and services
- Connecting clinicians to sepsis patient and survivor data
- Addressing the challenges of sepsis survivors
Sepsis is complex, it is difficult to predict, and it is difficult to identify which patients are most at risk. Early recognition of symptoms and intervention is imperative in order to mitigate long term severe outcomes. Products are needed that contribute to successful prevention, detection, prediction, treatment, and management of sepsis and its complications.
The Sepsis Innovation Collaborative brings together a diverse group of stakeholders involved in infection management all facing the same problem, to work together in order to overcome operational hurdles and lower barriers to innovation.
innovation collaborative organizational members
The formation of Sepsis Innovation Collaborative was informed by the incredibly generous donation of time, experience, and expertise of the following individuals, who comprised the inaugural Steering Committee:
The following Individual members have committed their time to furthering the goals of the Sepsis Innovation Collaborative
overcoming the obstacles of sepsis
The challenges of sepsis-related innovation are too large and/or too inefficient for a single stakeholder. Collaboration at each stage of a patient’s journey through survivorship is critical to identify and pursue opportunities to address these unmet needs and improve innovation and equity in infection management and sepsis care.
We’re seeking integration partners
We plan to build the broadest array of point-of-care molecular diagnostics and largest and best managed health dataset in the world. We seek partners that actively support APIs to enable users to have transparent interoperability of their health related data.